"Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosis"

Display By:

0

Edit your feedback below

Enter your reply below (Please read the How To)

Are you sure you want to delete your feedback?


0

Edit your feedback below

Enter your reply below (Please read the How To)

Are you sure you want to delete your feedback?

Load more (0)
Enter new comment below (Please read the How To)